Clinical Trial Update: Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intranasal octreotide for the treatment of diabetic macular edema. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetic Macular Edema | Phase 1 | Status: NOT_YET_RECRUITING